“…The difficulty in developing ASF vaccines is undoubtedly due to multifactorial processes including limited virus–host interaction understanding and complex nature of the virus (Tulman et al, ). ASFV encodes more than 80 structural proteins (Alejo, Matamoros, Guerra, & Andrés, ), which play crucial roles in virus attachment, entry and replication (Gómez‐Puertas et al, ; Jia, Ou, Pejsak, Zhang, & Zhang, ). Moreover, the diversity of ASFV isolates with varied virulence has complicated the task of defining immune protection determinants and remains a major gap in ASFV research (Dixon et al, ; Rowlands et al, ).…”